The retailer’s board will re-evaluate whether it pays a final dividend.
The retailer is cutting more than 300 jobs in a bid to cut costs.
The company's co-CEO Tim Brown describes it as a "giant leap for the shoe industry”.
The founder of Calocurb has found a natural alternative to anti-obesity drugs.